Affinity Capital Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$621K Sell
2,394
-38
-2% -$8.86K 0.08% 100
2026
Q1
$594K Sell
2,432
-9
-0.4% -$2.1K 0.08% 91
2025
Q4
$505K Buy
2,441
+724
+42% +$143K 0.07% 102
2025
Q3
$319K Sell
1,717
-395
-19% -$67.7K 0.05% 118
2025
Q2
$323K Sell
2,112
-428
-17% -$65.8K 0.06% 121
2025
Q1
$385K Hold
2,540
0.08% 105
2024
Q4
$371K Sell
2,540
-171
-6% -$26.5K 0.07% 111
2024
Q3
$439K Sell
2,711
-188
-6% -$30K 0.09% 104
2024
Q2
$424K Sell
2,899
-208
-7% -$30.9K 0.09% 102
2024
Q1
$492K Sell
3,107
-825
-21% -$131K 0.11% 94
2023
Q4
$616K Sell
3,932
-574
-13% -$88K 0.15% 79
2023
Q3
$702K Sell
4,506
-164
-4% -$27.1K 0.19% 71
2023
Q2
$773K Buy
4,670
+181
+4% +$29.2K 0.21% 66
2023
Q1
$696K Sell
4,489
-298
-6% -$48.1K 0.22% 62
2022
Q4
$846K Sell
4,787
-25
-0.5% -$4.32K 0.29% 48
2022
Q3
$786K Sell
4,812
-8
-0.2% -$1.35K 0.27% 49
2022
Q2
$856K Sell
4,820
-9
-0.2% -$1.6K 0.29% 46
2022
Q1
$856K Sell
4,829
-1,042
-18% -$177K 0.27% 51
2021
Q4
$1M Buy
5,871
+270
+5% +$44.2K 0.3% 47
2021
Q3
$905K Sell
5,601
-112
-2% -$19.1K 0.3% 48
2021
Q2
$941K Sell
5,713
-5
-0.1% -$828 0.32% 51
2021
Q1
$940K Buy
5,718
+117
+2% +$18.9K 0.34% 49
2020
Q4
$881K Sell
5,601
-143
-2% -$21.1K 0.36% 45
2020
Q3
$855K Buy
5,744
+205
+4% +$30.3K 0.48% 37
2020
Q2
$779K Buy
5,539
+42
+0.8% +$6.12K 0.51% 36
2020
Q1
$836K Sell
5,497
-485
-8% -$68.8K 0.61% 33
2019
Q4
$873K Buy
+5,982
New +$811K 0.57% 31

Other funds holding JNJ

Affinity Capital Advisors's JNJ Position: Q2 2026 in Review

Affinity Capital Advisors reduced its Johnson & Johnson (JNJ) stake by 1.6% in Q2 2026, selling an estimated $8.86K and leaving 2,394 shares worth $621K. The position accounts for 0.08% of the portfolio, ranked #100.

Affinity Capital Advisors first reported a position in JNJ in Q4 2019 and has held it in 27 quarters since. The position peaked at $1M in Q4 2021. 897 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Affinity Capital Advisors held 2,394 shares of Johnson & Johnson worth $621K as of Q2 2026.
  • Affinity Capital Advisors sold 38 Johnson & Johnson shares in Q2 2026, an estimated $8.86K.
  • Johnson & Johnson made up 0.08% of Affinity Capital Advisors's portfolio in Q2 2026, its #100 holding.
  • Affinity Capital Advisors first reported a position in Johnson & Johnson in Q4 2019 and has held it in 27 quarters since.
  • Affinity Capital Advisors's Johnson & Johnson position peaked at $1M in Q4 2021.
  • 897 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Affinity Capital Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.